688247.SHG Sinotherapeutics Inc. A

Healthcare Pharmaceuticals Shanghai Stock Exchange
7.95 CNY
Close of Nov 4, 2026
7.01 11.42
Market cap
CNY 3.60B
P/E
159.0x
P/B
2.68x
ROE
4.5%
Dividend yield
0.77%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688247.SHG undervalued?

Graham number

The Graham number of Sinotherapeutics Inc. A cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sinotherapeutics Inc. A fundamental analysis

No fundamental analysis for Sinotherapeutics Inc. A yet.

Sinotherapeutics Inc. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sinotherapeutics Inc. A

Sinotherapeutics Inc., a specialty pharmaceutical company, research, develops, manufactures, and commercializes generic and formulation products in China. The company's products are indicated for infection, oncology and rheumatology, gastroenterology and metabolism, neurology, cardiology, and nephrology. It offers posaconazole delayed-release tablets; olaparib, exemestane, and tofacitinib extended-release tablets; and mesalamine delayed-release, dapagliflozin and metformin h…

Full company profile